Clinical Trials Browser

montanide ISA 51 × Thoracic × 90 days × Clear all

NCT07169617 2026-03-19

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Phase 2 Not yet recruiting

Lung Neoplasms